Texas Based 4E Therapeutics Awarded National Institutes of Health Research Grant to Develop Non-Opioid Treatment for Pain to End Addiction
- Wednesday, November 10, 2021, 7:16
- Business
- Add a comment
AUSTIN, Texas., Nov. 10, 2021 /PRNewswire/ — 4E Therapeutics, Inc., a neuroscience company based in Austin, Texas developing a first-in-class treatment for neuropathic pain, announced that it has been awarded a $5.5 million Phase 2 National Institutes of Health (NIH) Small Business…
About the Author
adminasapcorp has written 41558 stories on this site.